| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |